Health Care
Coronavirus
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Commentary
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
Commentary
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Commentary
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Commentary
The coronavirus’s silent dental epidemic
By: Henry Miller, M.S., M.D., and Shiv Sharma, DDS As the nation slowly emerges from lockdown, we’re beginning to appreciate the full impact of the pandemic and that the sickness and death directly caused by the virus are only part of the picture. The three-month-plus suspension of routine, non-emergency medical ...
Commentary
Do coronavirus numbers show bias in health care? This study’s results will surprise you
African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Commentary
Trump not giving up on Obamacare repeal
After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive Democratic presidential nominee Joe ...
Coronavirus
Clark Judge – Political Communication Amidst a National Pandemic and Social Unrest
PRI Chairman and White House Writers Group founder and managing director Clark Judge evaluates how effectively political leaders in Washington, state capitols, and city halls are communicating with the public during the COVID-19 crisis and the social unrest following the death of George Floyd.
Business & Economics
PRI’s Hon. Dan Kolkey Quoted in Los Angeles Times on state executive orders
California’s mask order tests the limits of Newsom’s executive power By: Phil Willon Gov. Gavin Newsom’s order June 18 requiring all Californians to wear face masks came as welcome news to those in the state concerned by the recent surge in COVID-19 cases. Nevada City Mayor Reinette Senum instead greeted ...
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
The coronavirus’s silent dental epidemic
By: Henry Miller, M.S., M.D., and Shiv Sharma, DDS As the nation slowly emerges from lockdown, we’re beginning to appreciate the full impact of the pandemic and that the sickness and death directly caused by the virus are only part of the picture. The three-month-plus suspension of routine, non-emergency medical ...
Do coronavirus numbers show bias in health care? This study’s results will surprise you
African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Trump not giving up on Obamacare repeal
After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive Democratic presidential nominee Joe ...
Clark Judge – Political Communication Amidst a National Pandemic and Social Unrest
PRI Chairman and White House Writers Group founder and managing director Clark Judge evaluates how effectively political leaders in Washington, state capitols, and city halls are communicating with the public during the COVID-19 crisis and the social unrest following the death of George Floyd.
PRI’s Hon. Dan Kolkey Quoted in Los Angeles Times on state executive orders
California’s mask order tests the limits of Newsom’s executive power By: Phil Willon Gov. Gavin Newsom’s order June 18 requiring all Californians to wear face masks came as welcome news to those in the state concerned by the recent surge in COVID-19 cases. Nevada City Mayor Reinette Senum instead greeted ...
